AdventHealth Central and East Florida Media Resources
Have an account question? Check out our help center.
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
Choose the health content that’s right for you, and get it delivered right in your inbox.
In this episode of the Inspiring Wholeness podcast, Orlando Valkyries head coach Amy Pauly talks with Dr. Nicole Wilson, a Rothman Orthopaedics sports medicine physician at AdventHealth, about...
A new bladder cancer Phase II randomized trial opens in Central Florida. The V940 mRNA immunotherapy injection represents precision medicine at its best, according to Dr. Guru Sonpavde.
With type 1 diabetes on the rise, researchers at AdventHealth are trying to identify undiagnosed type 1 diabetes (T1D) in its early stages, in particular among the state’s underserved and minority...
Having breast cancer can be overwhelming and confusing, especially trying to understand treatment options. The goal of one program available to AdventHealth patients is to make it easy for them to...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.